JOSIE GREGAR: Open Payments
NPI 1770628281 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 37 payments from 12 companies in 2025. Trend: 2023 $172 · 2024 $307 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $219 |
| Axsome Therapeutics, Inc. | 4 | $182 |
| Lilly USA, LLC | 8 | $121 |
| Abbott Laboratories | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Novo Nordisk Inc | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Organon LLC | 1 | $17 |
Products named: VRAYLAR, Auvelity, MOUNJARO, FREESTYLE LIBRE 3, ZEPBOUND, REXULTI, AIRSUPRA, JARDIANCE.
Industry payments across SC — which companies pay providers there.
